Identification of a novel KIF13A-RET fusion in lung adenocarcinoma by next-generation sequencing.
Sign Up to like & getrecommendations! Published in 2018 at "Lung cancer"
DOI: 10.1016/j.lungcan.2017.08.019
Abstract: OBJECTIVES RET fusions have been reported in 1-2% of lung adenocarcinomas, and represent an actionable target. Patients whose tumors possess RET fusion are associated with clinical benefit from the treatment with multi-kinase inhibitors such as… read more here.
Keywords: novel kif13a; kif13a ret; ret fusion; cancer ... See more keywords